Nerbio, founded with the mission to revolutionize patient monitoring, focuses on creating mobile-connected devices that reduce healthcare costs while enhancing patient care. Their flagship product, iTOF, is the world's first neuromuscular blockade monitor controlled via a mobile phone. This innovative device aims to provide safe, simple, and smart monitoring solutions that are both economical and highly effective, targeting hospitals and healthcare providers seeking cost-effective, reliable patient monitoring tools.
Nerbio's notable achievements include the development and launch of the iTOF app, which allows for intuitive, hands-free monitoring on both iOS and Android platforms. The company offers a full year replacement warranty for their devices, emphasizing their commitment to quality and customer satisfaction. By making advanced medical technology accessible and affordable, Nerbio has significantly impacted the healthcare industry, enabling better patient outcomes and operational efficiencies in medical facilities.
